GAO Ballot Package
This page is part of the FHIR Specification (v1.1.0: STU 3 Ballot 1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions 
This is a frozen snapshot of the FHIR specification created for the purpose of balloting the GAO implementation Guide. It includes draft changes that may be part of the future DSTU 2.1 release but further change is expected. Readers should focus solely on the GAO implementation content, and FHIR DSTU 2 for other purposes.
FHIR Value set/code system definition for HL7 v2 table 0227 ( Manufacturers of Vaccines (code=MVX))
{
"resourceType": "ValueSet",
"id": "v2-0227",
"meta": {
"profile": [
"http://hl7.org/fhir/StructureDefinition/valueset-shareable-definition"
]
},
"text": {
"status": "additional",
"div": "<div>!-- Snipped for Brevity --></div>"
},
"url": "http://hl7.org/fhir/ValueSet/v2-0227",
"version": "2.8.2",
"name": "v2 Manufacturers of Vaccines (code=MVX)",
"status": "active",
"experimental": true,
"publisher": "HL7, Inc",
"contact": [
{
"telecom": [
{
"system": "other",
"value": "http://hl7.org"
}
]
}
],
"description": "FHIR Value set/code system definition for HL7 v2 table 0227 ( Manufacturers of Vaccines (code=MVX))",
"codeSystem": {
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-oid",
"valueUri": "urn:oid:2.16.840.1.133883.18.127"
}
],
"system": "http://hl7.org/fhir/v2/0227",
"caseSensitive": false,
"concept": [
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "(includes Ross Products Division)"
}
],
"code": "AB",
"display": "Abbott Laboratories",
"designation": [
{
"language": "nl",
"value": "Abbott Laboratories"
}
]
},
{
"code": "AD",
"display": "Adams Laboratories, Inc.",
"designation": [
{
"language": "nl",
"value": "Adams Laboratories, Inc."
}
]
},
{
"code": "ALP",
"display": "Alpha Therapeutic Corporation",
"designation": [
{
"language": "nl",
"value": "Alpha Therapeutic Corporation"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "[Inactive--use AVB]"
}
],
"code": "AR",
"display": "Armour",
"designation": [
{
"language": "nl",
"value": "Armour"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "(formerly Centeon L.L.C.; includes Armour Pharmaceutical Company) [Inactive--use ZLB] CDC Changes made on: Feb. 28, 2006"
}
],
"code": "AVB",
"display": "Aventis Behring L.L.C.",
"designation": [
{
"language": "nl",
"value": "Aventis Behring L.L.C."
}
]
},
{
"code": "AVI",
"display": "Aviron",
"designation": [
{
"language": "nl",
"value": "Aviron"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "[Inactive--use BAH]"
}
],
"code": "BA",
"display": "Baxter Healthcare Corporation",
"designation": [
{
"language": "nl",
"value": "Baxter Healthcare Corporation"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "(includes Hyland Immuno, Immuno International AG, and North American Vaccine, Inc.)"
}
],
"code": "BAH",
"display": "Baxter Healthcare Corporation",
"designation": [
{
"language": "nl",
"value": "Baxter Healthcare Corporation"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "(includes Miles, Inc. and Cutter Laboratories)"
}
],
"code": "BAY",
"display": "Bayer Corporation",
"designation": [
{
"language": "nl",
"value": "Bayer Corporation"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "[Inactive--use BPC]"
}
],
"code": "BP",
"display": "Berna Products",
"designation": [
{
"language": "nl",
"value": "Berna Products"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "(includes Swiss Serum and Vaccine Institute Berne)"
}
],
"code": "BPC",
"display": "Berna Products Corporation",
"designation": [
{
"language": "nl",
"value": "Berna Products Corporation"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "[Inactive--use AVB]"
}
],
"code": "CEN",
"display": "Centeon L.L.C.",
"designation": [
{
"language": "nl",
"value": "Centeon L.L.C."
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "[Inactive--use NOV] includes PowderJect Pharmaceuticals, Celltech Medeva Vaccines and Evans Medical Limited CDC Changes made on: July 14, 2006"
}
],
"code": "CHI",
"display": "Chiron Corporation",
"designation": [
{
"language": "nl",
"value": "Chiron Corporation"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "[Inactive--use NOV] CDC Changes made on: July 14, 2006"
}
],
"code": "CMP",
"display": "Celltech Medeva Pharmaceuticals",
"designation": [
{
"language": "nl",
"value": "Celltech Medeva Pharmaceuticals"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "CDC Changes made on: Feb. 28, 2006"
}
],
"code": "CNJ",
"display": "Cangene Corporation",
"designation": [
{
"language": "nl",
"value": "Cangene Corporation"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "[Inactive--use PMC]"
}
],
"code": "CON",
"display": "Connaught",
"designation": [
{
"language": "nl",
"value": "Connaught"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "CDC Changes made on: July 14, 2006"
}
],
"code": "DVC",
"display": "DynPort Vaccine Company, LLC",
"designation": [
{
"language": "nl",
"value": "DynPort Vaccine Company, LLC"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "[Inactive--use NOV] CDC Changes made on: July 14, 2006"
}
],
"code": "EVN",
"display": "Evans Medical Limited",
"designation": [
{
"language": "nl",
"value": "Evans Medical Limited"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "CDC Changes made on: July 14, 2006"
}
],
"code": "GEO",
"display": "GeoVax Labs, Inc.",
"designation": [
{
"language": "nl",
"value": "GeoVax Labs, Inc."
}
]
},
{
"code": "GRE",
"display": "Greer Laboratories, Inc.",
"designation": [
{
"language": "nl",
"value": "Greer Laboratories, Inc."
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "[Inactive--use BAH]"
}
],
"code": "IAG",
"display": "Immuno International AG",
"designation": [
{
"language": "nl",
"value": "Immuno International AG"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "[Inactive--use PMC]"
}
],
"code": "IM",
"display": "Merieux",
"designation": [
{
"language": "nl",
"value": "Merieux"
}
]
},
{
"code": "IUS",
"display": "Immuno-U.S., Inc.",
"designation": [
{
"language": "nl",
"value": "Immuno-U.S., Inc."
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "(BIKEN)"
}
],
"code": "JPN",
"display": "The Research Foundation for Microbial Diseases of Osaka University",
"designation": [
{
"language": "nl",
"value": "The Research Foundation for Microbial Diseases of Osaka University"
}
]
},
{
"code": "KGC",
"display": "Korea Green Cross Corporation",
"designation": [
{
"language": "nl",
"value": "Korea Green Cross Corporation"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "[Inactive--use WAL]"
}
],
"code": "LED",
"display": "Lederle",
"designation": [
{
"language": "nl",
"value": "Lederle"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "[Inactive--use MBL]"
}
],
"code": "MA",
"display": "Massachusetts Public Health Biologic Laboratories",
"designation": [
{
"language": "nl",
"value": "Massachusetts Public Health Biologic Laboratories"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "(formerly Massachusetts Public Health Biologic Laboratories)"
}
],
"code": "MBL",
"display": "Massachusetts Biologic Laboratories",
"designation": [
{
"language": "nl",
"value": "Massachusetts Biologic Laboratories"
}
]
},
{
"code": "MED",
"display": "MedImmune, Inc.",
"designation": [
{
"language": "nl",
"value": "MedImmune, Inc."
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "[Inactive--use BAY]"
}
],
"code": "MIL",
"display": "Miles",
"designation": [
{
"language": "nl",
"value": "Miles"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "(formerly Michigan Biologic Products Institute)"
}
],
"code": "MIP",
"display": "Bioport Corporation",
"designation": [
{
"language": "nl",
"value": "Bioport Corporation"
}
]
},
{
"code": "MSD",
"display": "Merck & Co., Inc.",
"designation": [
{
"language": "nl",
"value": "Merck & Co., Inc."
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "(formerly North American Biologicals, Inc.)"
}
],
"code": "NAB",
"display": "NABI",
"designation": [
{
"language": "nl",
"value": "NABI"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "[Inactive--use BAH]"
}
],
"code": "NAV",
"display": "North American Vaccine, Inc.",
"designation": [
{
"language": "nl",
"value": "North American Vaccine, Inc."
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "(includes Chiron, PowderJect Pharmaceuticals, Celltech Medeva Vaccines and Evans Limited, Ciba-Geigy Limited and Sandoz Limited)"
}
],
"code": "NOV",
"display": "Novartis Pharmaceutical Corporation",
"designation": [
{
"language": "nl",
"value": "Novartis Pharmaceutical Corporation"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "CDC Changes made on: July 14, 2006"
}
],
"code": "NVX",
"display": "Novavax, Inc.",
"designation": [
{
"language": "nl",
"value": "Novavax, Inc."
}
]
},
{
"code": "NYB",
"display": "New York Blood Center",
"designation": [
{
"language": "nl",
"value": "New York Blood Center"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "(formerly Ortho Diagnostic Systems, Inc.)"
}
],
"code": "ORT",
"display": "Ortho-Clinical Diagnostics",
"designation": [
{
"language": "nl",
"value": "Ortho-Clinical Diagnostics"
}
]
},
{
"code": "OTC",
"display": "Organon Teknika Corporation",
"designation": [
{
"language": "nl",
"value": "Organon Teknika Corporation"
}
]
},
{
"code": "OTH",
"display": "Other manufacturer",
"designation": [
{
"language": "nl",
"value": "Andere fabrikant"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "(formerly Parke-Davis)"
}
],
"code": "PD",
"display": "Parkedale Pharmaceuticals",
"designation": [
{
"language": "nl",
"value": "Parkedale Pharmaceuticals"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "(formerly Aventis Pasteur, Pasteur Merieux Connaught; includes Connaught Laboratories and Pasteur Merieux) CDC Changes made on: Feb. 28, 2006"
}
],
"code": "PMC",
"display": "sanofi pasteur",
"designation": [
{
"language": "nl",
"value": "sanofi pasteur"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "[Inactive--use WAL]"
}
],
"code": "PRX",
"display": "Praxis Biologics",
"designation": [
{
"language": "nl",
"value": "Praxis Biologics"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "(includes Celltech Medeva Vaccines and Evans Medical Limited) [Inactive--use NOV] CDC Changes made on: July 14, 2006"
}
],
"code": "PWJ",
"display": "PowderJect Pharmaceuticals",
"designation": [
{
"language": "nl",
"value": "PowderJect Pharmaceuticals"
}
]
},
{
"code": "SCL",
"display": "Sclavo, Inc.",
"designation": [
{
"language": "nl",
"value": "Sclavo, Inc."
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "[Inactive--use BPC]"
}
],
"code": "SI",
"display": "Swiss Serum and Vaccine Inst.",
"designation": [
{
"language": "nl",
"value": "Swiss Serum and Vaccine Inst."
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "(formerly SmithKline Beecham; includes SmithKline Beecham and Glaxo Welcome)"
}
],
"code": "SKB",
"display": "GlaxoSmithKline",
"designation": [
{
"language": "nl",
"value": "GlaxoSmithKline"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "CDC Changes made on: July 14, 2006"
}
],
"code": "SOL",
"display": "Solvay Pharmaceuticals",
"designation": [
{
"language": "nl",
"value": "Solvay, Pharmaceuticals"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "(includes Bayer Biologicals) CDC Changes made on: Feb. 28, 2006"
}
],
"code": "TAL",
"display": "Talecris Biotherapeutics",
"designation": [
{
"language": "nl",
"value": "Talecris Biotherapeutics"
}
]
},
{
"code": "UNK",
"display": "Unknown manufacturer",
"designation": [
{
"language": "nl",
"value": "Unknown manufacturer"
}
]
},
{
"code": "USA",
"display": "United States Army Medical Research and Material Command",
"designation": [
{
"language": "nl",
"value": "United States Army Medical Research and Material Command"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "CDC Changes made on: July 14, 2006"
}
],
"code": "VXG",
"display": "VaxGen",
"designation": [
{
"language": "nl",
"value": "VaxGen"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "[Inactive--use WAL]"
}
],
"code": "WA",
"display": "Wyeth-Ayerst",
"designation": [
{
"language": "nl",
"value": "Wyeth-Ayerst"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "(includes Wyeth-Lederle Vaccines and Pediatrics, Wyeth Laboratories, Lederle Laboratories, and Praxis Biologics)"
}
],
"code": "WAL",
"display": "Wyeth-Ayerst",
"designation": [
{
"language": "nl",
"value": "Wyeth-Ayerst"
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
"valueString": "(includes Aventis Behring and Armour Pharmaceutical Company) CDC Changes made on: Feb. 28, 2006"
}
],
"code": "ZLB",
"display": "ZLB Behring",
"designation": [
{
"language": "nl",
"value": "ZLB Behring"
}
]
}
]
}
}
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.
© HL7.org 2011+. FHIR DSTU2 (v1.1.0-7375) generated on Thu, Dec 3, 2015 10:01+1100.
Links: Search |
Version History |
Table of Contents |
Compare to DSTU1 |
|
Propose a change